REPORT ID 3816

EMEA (Europe, Middle East and Africa) Oral Solid Dosage Pharmaceutical Formulation Market Report 2019

Publish Date
2019
Pages
116
Format
Electronic (PDF)

In this report, the EMEA Oral Solid Dosage Pharmaceutical Formulation market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca Plc.
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    Gilead Sciences
    Merck & Co. Inc.
    Novartis AG
    Pfizer Inc.
    AbbVie Inc.
    Boehringer Ingelheim GmbH
    Hoffman-La-Roche Ltd.
    Johnson & Johnson
    Biogen Inc.
    Bayer AG
    Teva Pharmaceticals
    Amgen Inc.
    Takeda Pharmaceutical Company Ltd.
    Otsuka Pharmaceutical Co., Ltd.
    Shire Plc.
    Celgene Corporation
    Astellas Pharma Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Form
        Capsules
        Powders
        Tablets
    By Drug Release Mechanism
        Immediate Release
        Extended Release

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Oral Solid Dosage Pharmaceutical Formulation Market  Report 2019
1 Oral Solid Dosage Pharmaceutical Formulation Overview
    1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
    1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation
        1.2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Capsules
        1.2.4 Powders
        1.2.5 Tablets
    1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users
        1.3.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 EMEA Oral Solid Dosage Pharmaceutical Formulation Market by Region
        1.4.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation ( 2014-2024)
        1.5.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate ( 2014-2024)

2 EMEA Oral Solid Dosage Pharmaceutical Formulation Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Competition by Players/Manufacturers
        2.1.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price by Players ( 2014-2019)
    2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Type/Product Category
        2.2.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sale Price by Type ( 2014-2019)
    2.3 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume) by Application
    2.4 EMEA Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Region
        2.4.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Price by Region ( 2014-2019)

3 Europe Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Value ( 2014-2019)
        3.1.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    3.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    3.4 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries ( 2014-2019)
        3.4.3 Germany Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        3.4.4 France Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)

4 Middle East Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Value ( 2014-2019)
        4.1.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    4.3 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    4.4 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)

5 Africa Oral Solid Dosage Pharmaceutical Formulation (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Value ( 2014-2019)
        5.1.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type
    5.3 Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Application
    5.4 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Oral Solid Dosage Pharmaceutical Formulation Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Oral Solid Dosage Pharmaceutical Formulation Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate ( 2014-2019)

6 EMEA Oral Solid Dosage Pharmaceutical Formulation Manufacturers/Players Profiles and Sales Data
    6.1 AstraZeneca Plc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Bristol-Myers Squibb Company
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly and Company
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Gilead Sciences
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Merck & Co. Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 AbbVie Inc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Boehringer Ingelheim GmbH
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Hoffman-La-Roche Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Johnson & Johnson
    6.12 Biogen Inc.
    6.13 Bayer AG
    6.14 Teva Pharmaceticals
    6.15 Amgen Inc.
    6.16 Takeda Pharmaceutical Company Ltd.
    6.17 Otsuka Pharmaceutical Co., Ltd.
    6.18 Shire Plc.
    6.19 Celgene Corporation
    6.20 Astellas Pharma Inc.

7 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Cost Analysis
    7.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Oral Solid Dosage Pharmaceutical Formulation Market Forecast ( 2019-2025)
    11.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Oral Solid Dosage Pharmaceutical Formulation Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (